Jason D. Hanson
Equibles does not estimate personal net worth.
Get an email with a short summary when enGene Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ENGN alertsAbout Jason D. Hanson
enGene Therapeutics Inc. reported in an 8-K filed July 24, 2024 that Jason D. Hanson resigned as director, effective July 21, 2024. enGene Therapeutics Inc. reported in an 8-K filed July 24, 2024 that Jason D. Hanson resigned as Chief Executive Officer, effective July 21, 2024. The proxy statement of enGene Therapeutics Inc. reports total compensation of $999,299 for Jason D. Hanson in fiscal 2024, including a base salary of $427,283. Disclosed compensation is on record for 3 fiscal years. enGene Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at enGene Therapeutics Inc. includes Ron Cooper (CEO and Board Member), Ronald H. W. Cooper (CEO and Board Member), Ronald H.W. Cooper (CEO and Board Member) and 7 others.
“Mr. Hanson’s separation from the Company and resignation as a director became effective July 21, 2024, and his resignation is not the result of any disagreement with the Company.”
“Mr. Cooper succeeds Jason D. Hanson, who, as previously announced, informed the Company of his decision to resign pending the Company’s completion of its search for his successor.”
Affiliation history
-
enGene Therapeutics Inc. (ENGN)
SEC 8-K
Current2023-10-31–present
-
Start not stated–2024-07-21
-
Start not stated–2024-07-21
-
Start not stated–2024-02-14
-
Start not stated–2024-02-14
Company network
Leadership on record at enGene Therapeutics Inc.
- Ron Cooper CEO, Board Member
- Ronald H. W. Cooper CEO, Board Member
- Ronald H.W. Cooper CEO, Board Member
- Ryan Daws CFO
- Alex Nichols COO
- Alexander Nichols COO
- Dr. Alex Nichols COO
- Anthony Cheung CTO
- Joan Connolly CTO
- Dr. William Grossman Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | enGene Therapeutics Inc. (ENGN) | Former Chief Executive Officer | $427,283 | $999,299 |
| 2023 | enGene Therapeutics Inc. (ENGN) | Former Chief Executive Officer | $442,337 | $2,192,934 |
| 2022 | enGene Therapeutics Inc. (ENGN) | Chief Executive Officer | $446,419 | $649,207 |